Alps Advisors Inc Pharvaris N.V. Transaction History
Alps Advisors Inc
- $15.7 Billion
- Q4 2024
A detailed history of Alps Advisors Inc transactions in Pharvaris N.V. stock. As of the latest transaction made, Alps Advisors Inc holds 43,671 shares of PHVS stock, worth $675,153. This represents 0.01% of its overall portfolio holdings.
Number of Shares
43,671
Previous 42,308
3.22%
Holding current value
$675,153
Previous $783,000
6.9%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PHVS
# of Institutions
53Shares Held
39.1MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY7.53MShares$116 Million5.17% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA4.4MShares$68 Million77.49% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.29MShares$66.3 Million67.66% of portfolio
-
Viking Global Investors LP3.65MShares$56.5 Million0.24% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.3MShares$51.1 Million17.1% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $522M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...